Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:08 AM
Study NCT ID:
NCT00112827
Status:
COMPLETED
Last Update Posted:
2025-06-06
First Post:
2005-06-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-02
First Submit QC Date:
None
Study First Post Date:
2005-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-21
Results First Submit QC Date:
None
Results First Post Date:
2021-03-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-04
Last Update Post Date:
2025-06-06
Last Update Post Date Type:
ACTUAL